The increased gallstone risk may be attributable to two mechanisms: the rapid and substantial weight loss these medications facilitate, and potentially direct effects of GLP-1 agonists on reducing gallbladder motility and emptying
It is known to reduce feelings of hunger while increasing feelings of nausea
Recent evidence has shown that anti-amyloid drugs, another type of medication being investigated for Alzheimers disease, may be effective at combating cognitive decline, however, those drugs come with potential serious side effects, like brain bleeding and swelling
Based on the convergent evidence from enrichment analysis, molecular docking, and animal validation, we have identified Akt as the key target of LC against myocarditis: it exhibits optimal topological centrality in the PPI network, demonstrates the strongest binding affinity with LC, and serves as a signaling hub in the PI3K/Akt pathway that is closely associated with the pathological progression of myocarditis
Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimers disease
This new oral medication is in development.
